- Investing Ideas
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥59.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥133.00
7D
12.6%
1Y
38.5%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥39.6b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥44.22
7D
-15.5%
1Y
17.8%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥14.9b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥41.59
7D
0.4%
1Y
8.2%